Dianne S Sako

This inventor holds 53 USPTO granted patents and 22 published patent applications, plus 6 CIPO patents and 16 EPO patents, primarily in TGF-Beta Receptor Biology. Top assignees: Acceleron Pharma Inc., Genetics Institute, Inc., Adimab, LLC. Active years: 1998-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dianne S Sako. Retrieved from https://idiyas.com/inventor/dianne-s-sako

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 53 (Patent Applications = 22)

% Patents Active = 84.9

CIPO Patents = 6 (Patent Applications = 13)

EPO Patents = 16 (Patent Applications = 27)

Average Co-Inventor Count = 4.7

ph-index = 8

Forward Citations = 272(Granted Patents)

Forward Citations (Not Self Cited) = 220(Dec 10, 2025)

Location History:

Boston, MA (US) (1998 - 2012)
Medford, MA (US) (2006 - 2024)
Cambridge, MA (US) (2019 - 2024)

Company Filing History:

39 out of 172

Acceleron Pharma Inc.

patents

12 out of 392

Genetics Institute, Inc.

The Brigham and Women's Hospital, Inc.

patents

5. 1 out of 1

Accerelon Pharma Inc.

where one patent can have more than one assignee

Years Active: 1998-2026

Loading Chart...

Areas of Expertise:

TGF-Beta Receptors

Heteromultimers

Binding Proteins

ALK4

ALK7

Muscular Dystrophy

Pulmonary Hypertension

Fusion Polypeptides

Activin Type 2

Fibrotic Disorder

Sclerotic Disorder

P-Selectin Ligand

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12673998 - ALK7 Binding Proteins and Uses Thereof (2026-07-07),

2. 12545736 - ACTRII-BINDING PROTEINS AND USES THEREOF (2026-02-10),

3. 12421295 - TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof (2025-09-23),

4. 12365736 - ALK7 binding proteins and uses thereof (2025-07-22),

5. 12338273 - Single-arm type I and type II receptor fusion proteins and uses thereof (2025-06-24),

6. 12258380 - ALK4:actriib heteromultimers and uses thereof (2025-03-25),

7. 12195519 - Transforming growth factor-beta (TGF-beta) receptor type II fusion polypeptides (2025-01-14),

8. 12168683 - Binders of TGFβ-superfamily ligands and uses thereof (2024-12-17),

9. 12145970 - Twisted gastrulation polypeptides and uses thereof (2024-11-19),

10. 12103959 - Multispecific binders of TGFBeta-superfamily ligands and uses thereof (2024-10-01),

11. 12054753 - Methods of treatment of muscular dystrophy with ALK4:ActRIIB heteromultimers (2024-08-06),

12. 12042524 - Activin type 2 receptor binding proteins methods of making them (2024-07-23),

13. 12024563 - ALK7 antagonists and uses thereof (2024-07-02),

14. 11981738 - ALK7 binding proteins and uses thereof (2024-05-14),

15. 11951156 - Methods for treating pulmonary hypertension with a ligand binding domain of a TGF-beta type II receptor (2024-04-09),

Title: The Innovative Mind of Dianne S Sako

Introduction: Dianne S Sako is a pioneering inventor based in Boston, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Dianne S Sako holds several patents in the areas of technology and healthcare, showcasing her versatility and ingenuity.

Career Highlights: With a career spanning over two decades, Dianne S Sako has consistently pushed the boundaries of innovation, leading to significant advancements in her respective industries.

Collaborations: Throughout her career, Dianne S Sako has collaborated with leading researchers, engineers, and professionals, fostering a culture of innovation and excellence.

Conclusion: Dianne S Sako's passion for innovation and her relentless pursuit of excellence continue to inspire the next generation of inventors and creators.

Profile summary based on public USPTO records.